A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H
Sophie Chauvet(Assistance Publique – Hôpitaux de Paris), Véronique Frémeaux‐Bacchi(Assistance Publique – Hôpitaux de Paris), Guy Touchard(Centre Hospitalier Universitaire de Poitiers), Lubka T. Roumenina(Université Paris Cité), Maria Chiara Marinozzi(Délégation Paris 5), Sarah Bruneau(Inserm), Jean‐Claude Aldigier(Hôpital Dupuytren), Anuja Java(Washington University in St. Louis), Frank Bridoux(Université de Poitiers), John P. Atkinson(Washington University in St. Louis), Tania Rybkine(Délégation Paris 5), Elizabeth C. Schramm(Washington University in St. Louis)
Cited by 47
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Complement System Part I – Molecular Mechanisms of Activation and Regulation
|Frontiers in Immunology|2015|1.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809